Wescott Financial Advisory Group, LLC Penumbra Inc Transaction History

Wescott Financial Advisory Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$220.43 - $278.69 $187,365 - $236,886	850 New	850 $236,000
Q1 2022 May 16, 2022	SELL	$187.51 - $283.98 $159,383 - $241,383	-850 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$238.08 - $288.0 $1,428 - $1,728	-6 Reduced 0.7%	850 $244,000
Q3 2021 Oct 29, 2021	BUY	$250.72 - $291.24 $1,504 - $1,747	6 Added 0.71%	856 $228,000
Q1 2021 Jun 25, 2021	BUY	$175.6 - $291.43 $149,260 - $247,715	850 New	850 $230,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.09B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Wescott Financial Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wescott Financial Advisory Group, LLC with notifications on news.